Heron Therapeutics Inc (HRTX)

EBITDA Margin

-13.37%

Quarterly · Period ending:

HRTX logo

HRTX EBITDA Margin

Latest reported-13.37%
HRTX Quarterly EBITDA Margin (100.00% → -13.37%)
High-resolution chart · PNG

HRTX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-152.2%
-135.3613%
-199.3159%
-100.3878%
-116.6806%
-15.4111%
13.0841%
-13.8776%
12.766%
19.5652%
34.6154%
14.2857%
13.7255%
13.0435%
8.6957%
-2.439%
-4.4444%
18%
-36.8421%
-34.0909%
-25.9259%
-25%
-96.875%
-58.0645%
-36.1702%
-11.7647%
-46.6667%
-79.4118%
-56.8182%
-31.3725%
-52.0833%
-58.5366%
-50.9804%
-76%
-79.1667%
-35%
-36.3636%
-271.4286%
-275%
-200%
-13.3333%
-250%
-142.8571%
-275%
-112.5%
-133.3333%
-183.3333%
-180%
-76.9231%
100%
-1,580%
100%
100%
100%
-728.5714%
100%
100%
100%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.